CBA 2017 Annual Conference

HO Family Scholarship (CBA) is available thanks to the generosity of Ho family. Details and Application form here.

2016 Annual Conference Highlights

CBA 2017 Annual Conference registration open
(Online registration closed):
CBA Members:
$30 online (closed). Lunch included.
$40 onsite. Lunch not guaranteed.
$50 online (closed). Lunch included.
$60 onsite. Lunch not guaranteed.

2017 CBA Annual Conference Current Agenda

Date & Time: Oct. 14, 2017 (8:00am-4:30pm PDT)
Location: Crowne Plaza, Foster City, CA
Theme: Promoting Biosciences for Better Human Health- CBA 20th Anniversary

8:00-8:30 am Registration, Breakfast and Exhibitions
8:30 – 8:35 am Welcome and Opening Remarks

Patrick Yang, Ph.D., CBA president

8:35 – 8:40 am Conference Introduction

Huifang Li, Ph.D., CBA Conference Chair

Introduction: Lin Sun-Hoffman, Ph.D.
8:40 – 9:20 am Keynote Presentation: Innovative Drug Development: Maximizing Success and Value

Peony Yu, M.D. (CMO, Fibrogen Inc.)

Introduction: Mr. Caesar Ho
9:20 – 9:45 am Cepheid: from Rags to Riches

Kurt Petersen, Ph.D. (Co-Founder, Cepheid Inc.)

Panel Discussion I

Moderator: Mr. Caesar Ho & Mr. Ravi Mistry

9:45 – 10:25 am Entrepreneurship

Paul Hung, Ph.D. (CEO, COMBiNATi)

Ben Hwang (CEO, Profusa)

Dan Laser Ph.D. (CEO, Applaud Medical, Inc.)

Ben Wang, Ph.D. (Co-founder, Chimera Bioengineering)

Chandler Robinson, M.D. (CEO, Monopar Therapeutics)

10:25-10:40 am Networking and Exhibitions
10:40 – 11:05 am Build Scientist Town to Save Lives with Frontier Science and Technology

Mr. William Wei (VP of America Frontier Science Institute & Chief Architect of American Chinese Friendship Council)

11:05 – 11:30 am Opportunities for Biosimilar Companies under U.S. Legal System

Patricia Campbell, Ph.D. (Partner, Jones Day)

Bing Liang, Ph.D. (Associate Attorney, Jones Day)

11:30-11:45 am Sponsors speech
11:45-11:50 am Ho Family Scholarship

Mr. Caesar Ho

11:50 am – 12:00 pm CBA 20 years’ Review

Patrick Yang, Ph.D.

12:00-12:30 pm Lunch and Exhibitions
Introduction: Michelle Chen, Ph.D.
12:30 – 1:10 pm Keynote presentation: Avastin’s Development: The Case Study for Mega Brand

Philippe Bishop, M.D. (CMO,, Inc.)

1:10 – 1:35 pm Merck San Francisco: Commitment to Science-driven Transformational Medicines

James Mu, Ph.D. (Merck Research Laboratories San Francisco)

1:35 – 2:00 pm Transformation of BeiGene via Business Development and Partnership

Ji Li, Ph.D. (EVP, BeiGene)

2:00 – 2:15 pm Networking and Exhibitions

Panel Discussion II

Moderator: Michelle Chen, Ph.D.

2:15 - 2:55 pm Biotech Investment

Jennifer Hu, Ph.D. (Partner, Qiming US Healthcare Fund)

Alexi Ji, Ph.D./MBA (Partner, Illumina Ventures)

Rajeev Dadoo, Ph.D./MBA (Partner, SR One)

Vincent Xiang, Ph.D./MBA (Partner, Six Dimensions Capital)

Panel Discussion III

Moderator: Patty Kiang, Ph.D.

2:55 – 3:45 pm Biotech Supply Chain

Lee-Cheng Liu, Ph.D. (President & CEO, Eirgenix)

Ray Chen, Ph.D. (Sr. Director, Genscript)

Amit Chaudhuri, Ph.D. (VP, Medgenome)

Dan Zhang, Ph.D. (CEO, Fountain Medical Development)

Panel Discussion IV

Moderator: Lin Sun-Hoffman, Ph.D.

3:45 – 4:15 pm East West Convergence - One Mind, Two Coasts
4:15 – 4:25 pm Former CBA President Speech

Shian-Jiun Shih, Ph.D. (CBA founding President)

4:25 – 4:30 pm Closing Remarks

Huifang Li, Ph.D., CBA Conference Chair

4:30 – 7:00 pm Networking Reception